Weight Loss with Conn's Syndrome (Primary Hyperaldosteronism) in South Africa

How Excess Aldosterone Drives Weight Gain and Blocks Loss

Aldosterone is a mineralocorticoid hormone that instructs the kidneys to retain sodium and excrete potassium. In normal physiology this is a short-term blood pressure rescue mechanism. In Conn's syndrome it runs continuously and autonomously — with the following downstream consequences for weight:

Diagnosis: Knowing Where You Stand

The screening test for primary hyperaldosteronism is an aldosterone-to-renin ratio (ARR) taken first thing in the morning. In Conn's syndrome, aldosterone is high and renin is suppressed, giving a very elevated ratio. This simple blood test is inexpensive and available at most South African private pathology labs (Ampath, Lancet, Pathcare).

If your ARR is elevated, your endocrinologist will proceed to confirmatory testing (salt suppression test or fludrocortisone suppression test) and adrenal vein sampling or CT scan to determine whether the problem is a single adenoma (surgically curable) or bilateral adrenal hyperplasia (managed with medication).

Post-Treatment Weight: What to Expect

After Adrenalectomy (Surgical Cure)

Patients who undergo laparoscopic adrenalectomy for a unilateral adenoma typically experience:

• Week 1–2: Diuresis — the kidneys shed the retained sodium and fluid. Scale drops 3–6 kg without any dietary effort.
• Month 1–3: Blood pressure normalises in ~50% of patients without medication. The remaining 50% need fewer drugs at lower doses.
• Month 3–6: Insulin sensitivity improves. Visceral fat begins to reduce. Weight loss efforts become effective for the first time in years.
• Long-term: A modest, sustainable deficit of 300–500 kcal/day combined with regular activity produces the standard 0.5–1 kg/week loss seen in otherwise healthy people.

On Medical Management (Spironolactone / Eplerenone)

For bilateral adrenal hyperplasia or patients unsuitable for surgery, aldosterone receptor blockade produces similar fluid loss but requires ongoing medication. Key points:

• Spironolactone (Aldactone) is the standard first-line drug in South Africa — available on the Essential Medicines List.
• Eplerenone is more selective (fewer anti-androgen side effects in men) but significantly more expensive and not on formulary at all schemes.
• Spironolactone causes potassium retention — do not supplement potassium separately without checking levels. Hyperkalaemia is a real risk.
• Spironolactone has anti-androgen effects — can reduce libido in men and cause menstrual irregularities in women. Discuss with your doctor.

Sodium: The Most Important Dietary Lever

Before treatment, high dietary sodium dramatically worsens fluid retention and blood pressure in Conn's syndrome. After treatment (surgical or medical), modest sodium restriction remains beneficial for blood pressure control and reduces the medication dose needed.

Practical sodium targets for Conn's syndrome

• Pre-treatment: Reduce to <2 g sodium/day (5 g salt/day) — this is the WHO recommended maximum for all adults and is particularly important here.
• Post-treatment: <2 g sodium/day remains ideal; many treated patients can relax to 2.3 g (the national general guideline) once blood pressure stabilises.
• Never go very low sodium (<1 g/day) without medical supervision — extreme sodium restriction can activate compensatory renin-angiotensin responses that partially offset the benefit of treatment.

High-sodium South African foods to moderate

Potassium: The Essential Replenishment Mineral

Hypokalaemia (low blood potassium) in Conn's syndrome causes profound muscle weakness, fatigue, constipation, and cardiac arrhythmias. Before treatment is optimised, and sometimes transiently after, ensuring adequate potassium intake is important — but this must be done through food (not supplements) unless your doctor prescribes otherwise, as potassium supplements combined with spironolactone can cause dangerous hyperkalaemia.

Potassium-rich foods appropriate for Conn's syndrome

• Butternut squash — 580 mg potassium per 200 g serving; naturally low sodium; versatile in SA cooking
• Sweet potato — 540 mg per medium potato; excellent low-GI starchy base
• Spinach / morogo — 840 mg per cooked cup; widely available, affordable, culturally appropriate
• Avocado — 485 mg per half; healthy fats, excellent satiety for weight management
• Lentils — 730 mg per cooked cup; high protein, low GI, very affordable
• Banana — 422 mg; portable, practical, good pre-workout snack
• Rooibos tea — negligible potassium but hydrates well; naturally sodium-free; SA staple

Calorie Management and Weight Loss Strategy

Once aldosterone is controlled (post-op or 4–6 weeks into effective medical therapy), normal weight loss principles apply. However, a few Conn's-specific considerations remain:

Dietary approach

• Target deficit: 400–600 kcal/day below maintenance — modest but sustainable once fluid weight has dropped and energy levels improve.
• Prioritise protein: 1.2–1.6 g/kg body weight daily. Hypokalaemia-driven muscle loss (pre-treatment) leaves many patients with reduced lean mass. Higher protein intake during weight loss preserves what remains while you rebuild.
• Low-GI carbohydrates: Insulin resistance is a feature of primary hyperaldosteronism. Low-GI foods (legumes, oats, butternut, most vegetables) reduce glycaemic load and improve insulin sensitivity alongside the improvement from aldosterone control.
• Avoid ultra-processed food: Packed with hidden sodium and saturated fats — doubly problematic here. Cook from scratch where possible.
• Moderate healthy fats: Avocado, olive oil, nuts (unsalted) — these add satiety and have favourable blood pressure effects.

Interpreting the scale

This is critical: during the first 2–6 weeks of treatment, the scale may drop 4–8 kg rapidly. This is fluid loss, not fat. Do not be discouraged when this rapid initial drop slows to 0.3–0.7 kg/week — that subsequent, slower loss is genuine fat. Track waist circumference and how clothes fit alongside scale weight.

Exercise: Rebuilding Safely After Years of Hypokalaemia

Many Conn's patients have avoided exercise for years because of weakness, cramps, and dangerous blood pressure spikes with exertion. Once treatment begins and potassium normalises, a gradual return to activity is essential for weight management.

Blood Pressure Medications and Weight — What to Know

Many patients with Conn's syndrome are on multiple blood pressure medications. Some have weight implications:

• Beta-blockers (atenolol, metoprolol): Commonly cause weight gain of 1–3 kg via slowed metabolism and fatigue. If you are on these and Conn's is confirmed, discuss with your doctor whether they can be replaced once aldosterone is controlled — most patients with Conn's do not require beta-blockers long-term.
• Thiazide diuretics (hydrochlorothiazide): Often prescribed for resistant hypertension in undiagnosed Conn's. These worsen hypokalaemia and should ideally be discontinued once a mineralocorticoid antagonist is started.
• ACE inhibitors / ARBs (enalapril, losartan): Generally weight-neutral. Often continued post-treatment for additional renoprotection.
• Calcium channel blockers (amlodipine): Can cause ankle oedema — not fluid retention from aldosterone but peripheral vasodilation. Distinguish from Conn's-related oedema before assuming it is treatment-related.

Monitoring Progress: What to Track

Weight management with Conn's syndrome requires more nuanced tracking than a simple scale number:

• Blood pressure: Target below 130/80 once treated. Track at home morning and evening.
• Serum potassium: 3.5–5.0 mmol/L target. Checked 4–6 weekly initially on spironolactone, then 3-monthly when stable.
• Aldosterone-to-renin ratio: Periodic re-check to confirm treatment efficacy.
• Waist circumference: Monthly. More reliable than weight alone during initial fluid-loss phase.
• Fasting glucose and HbA1c: Insulin resistance often improves after treatment — monitor to confirm and adjust carbohydrate intake accordingly.
• Kidney function (eGFR, creatinine): Spironolactone can impair GFR mildly, especially in older patients or those with pre-existing kidney disease.

Practical Weekly Meal Framework

Below is a framework suited to the post-treatment Conn's patient in a South African context. Adjust portions to your calorie target (typically 1400–1800 kcal/day for women, 1600–2000 for men, depending on activity).

Summary: Key Rules for Conn's Syndrome Weight Management

1. Get properly diagnosed first — an ARR blood test is the starting point. Uncontrolled Conn's makes weight loss nearly impossible.
2. Treat the cause — adrenalectomy (if unilateral adenoma) or spironolactone/eplerenone (if bilateral) must precede any meaningful weight loss effort.
3. Restrict sodium to <2 g/day — this is the most powerful dietary lever before and after treatment.
4. Do not supplement potassium unless prescribed — if on spironolactone, food sources of potassium are sufficient and safer.
5. Expect fluid loss first (weeks 1–6 post-treatment), then pursue a 400–600 kcal/day deficit for genuine fat loss.
6. Prioritise protein and low-GI carbohydrates — insulin resistance is a component that diet can help address.
7. Exercise progressively — only once blood pressure is controlled and potassium is normal.
8. Always consult your endocrinologist before making significant dietary or exercise changes — especially if on multiple blood pressure medications or spironolactone.